661 related articles for article (PubMed ID: 27892494)
21. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy.
Alves S; Castro L; Fernandes MS; Francisco R; Castro P; Priault M; Chaves SR; Moyer MP; Oliveira C; Seruca R; Côrte-Real M; Sousa MJ; Preto A
Oncotarget; 2015 Oct; 6(31):30787-802. PubMed ID: 26418750
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the circular RNA transcriptome in endometrial cancer.
Chen BJ; Byrne FL; Takenaka K; Modesitt SC; Olzomer EM; Mills JD; Farrell R; Hoehn KL; Janitz M
Oncotarget; 2018 Jan; 9(5):5786-5796. PubMed ID: 29464034
[TBL] [Abstract][Full Text] [Related]
24. Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant
Nishi K; Luo H; Ishikura S; Doi K; Iwaihara Y; Wills L; Baillie GS; Sakata T; Shirasawa S; Tsunoda T
Anticancer Res; 2017 Jul; 37(7):3833-3839. PubMed ID: 28668883
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data.
Xu T; Wu J; Han P; Zhao Z; Song X
BMC Genomics; 2017 Oct; 18(Suppl 6):680. PubMed ID: 28984197
[TBL] [Abstract][Full Text] [Related]
26. Circular RNAs and exosomes in cancer: a mysterious connection.
Hou J; Jiang W; Zhu L; Zhong S; Zhang H; Li J; Zhou S; Yang S; He Y; Wang D; Chen X; Deng F; Zhang Q; Wang J; Hu J; Zhang W; Ding L; Zhao J; Tang J
Clin Transl Oncol; 2018 Sep; 20(9):1109-1116. PubMed ID: 29536331
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer.
Chen B; Huang S
Cancer Lett; 2018 Apr; 418():41-50. PubMed ID: 29330104
[TBL] [Abstract][Full Text] [Related]
28. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.
Li Y; Wang J; Gao X; Han W; Zheng Y; Xu H; Zhang C; He Q; Zhang L; Li Z; Zhou D
PLoS One; 2014; 9(11):e113186. PubMed ID: 25427200
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA expression in exosomes derived from breast cancer cells and patients.
Wang J; Zhang Q; Zhou S; Xu H; Wang D; Feng J; Zhao J; Zhong S
Epigenomics; 2019 Feb; 11(4):411-421. PubMed ID: 30785332
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA profile of infantile hemangioma by microarray analysis.
Fu C; Lv R; Xu G; Zhang L; Bi J; Lin L; Liu X; Huo R
PLoS One; 2017; 12(11):e0187581. PubMed ID: 29095957
[TBL] [Abstract][Full Text] [Related]
31. A Facile Method to Engineer Mutant Kras Alleles in an Isogenic Cell Background.
Budagyan K; Chernoff J
Methods Mol Biol; 2021; 2262():323-334. PubMed ID: 33977487
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in circular RNAs in human cancers.
Huang G; Li S; Yang N; Zou Y; Zheng D; Xiao T
Cancer Lett; 2017 Sep; 404():8-18. PubMed ID: 28705773
[TBL] [Abstract][Full Text] [Related]
33. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
[TBL] [Abstract][Full Text] [Related]
34. A set of defined oncogenic mutation alleles seems to better predict the response to cetuximab in CRC patient-derived xenograft than KRAS 12/13 mutations.
Chen D; Huang X; Cai J; Guo S; Qian W; Wery JP; Li QX
Oncotarget; 2015 Dec; 6(38):40815-21. PubMed ID: 26512781
[TBL] [Abstract][Full Text] [Related]
35. Expression profile of circular RNAs in human gastric cancer tissues.
Huang YS; Jie N; Zou KJ; Weng Y
Mol Med Rep; 2017 Sep; 16(3):2469-2476. PubMed ID: 28737829
[TBL] [Abstract][Full Text] [Related]
36. The emerging role of circular RNAs in transcriptome regulation.
Huang S; Yang B; Chen BJ; Bliim N; Ueberham U; Arendt T; Janitz M
Genomics; 2017 Oct; 109(5-6):401-407. PubMed ID: 28655641
[TBL] [Abstract][Full Text] [Related]
37. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
38. Circular RNAs and cancer.
He J; Xie Q; Xu H; Li J; Li Y
Cancer Lett; 2017 Jun; 396():138-144. PubMed ID: 28342987
[TBL] [Abstract][Full Text] [Related]
39. KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.
Malapelle U; Sgariglia R; De Stefano A; Bellevicine C; Vigliar E; de Biase D; Sepe R; Pallante P; Carlomagno C; Tallini G; Troncone G
J Clin Pathol; 2015 Apr; 68(4):265-9. PubMed ID: 25609577
[TBL] [Abstract][Full Text] [Related]
40. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
